Imaging the Aetiology of Sleep Disorders in Dementia and Parkinson’s Disease

Current Neurology and Neuroscience Reports

Volumn 14, Issue 12, 2014, Pages

  Pavese, Nicola ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Alzheimer s disease; Dementia; Imaging; Parkinson s disease; PET; Sleep disorders; SPECT

Indexed keywords

ACETYLCHOLINESTERASE; CARBON 11; FLUORODEOXYGLUCOSE F 18; IODINE 123; TECHNETIUM 99M;

ALZHEIMER DISEASE; BRAIN CORTEX; DAYTIME SOMNOLENCE; ENZYME ACTIVITY; FRACTIONAL ANISOTROPY; HUMAN; MIDDLE FRONTAL GYRUS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASOMNIA; PARKINSON DISEASE; PATHOGENESIS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRECUNEUS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; COMPLICATION; DEMENTIA; METABOLISM; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SLEEP WAKE DISORDERS;

DEMENTIA; HUMANS; NEUROIMAGING; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; SLEEP WAKE DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84910622554     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-014-0501-5     Document Type: Review

References (64)

1. Raggi A, Ferri R. Sleep disorders in neurodegenerative diseases. Eur J Neurol. 2010;17(11):1326–38.
2. Schrempf W, Brandt MD, Storch A, Reichmann H. Sleep disorders in Parkinson’s disease. J Parkinsons Dis. 2014;4(2):211–21.
3. McCurry SM, Ancoli-Israel S. Sleep dysfunction in Alzheimer’s disease and other dementias. Curr Treat Options Neurol. 2003;5(3):261–72.
4. Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 2013;12(5):443–53.
5. Karlsson KA, Kreider JC, Blumberg MS. Hypothalamic contribution to sleep-wake cycle development. Neuroscience. 2004;123(2):575–82.
6. Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci. 2002;5(Suppl):1071–5.
7. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci. 2003;23(1):7–11.
8. Schwartz JR, Roth T. Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol. 2008;6(4):367–78.
9. Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15) O PET study. Brain. 1997;120(Pt 7):1173–97.
10. Maquet P, Degueldre C, Delfiore G, Aerts J, Péters JM, Luxen A, et al. Functional neuroanatomy of human slow wave sleep. J Neurosci. 1997;17(8):2807–12.
11. Maquet P. Functional neuroimaging of normal human sleep by positron emission tomography. J Sleep Res. 2000;9(3):207–31.
12. Buchsbaum MS, Hazlett EA, Wu J, Bunney WE. Positron emission tomography with deoxyglucose-F18 imaging of sleep. Neuropsychopharmacology. 2001;25 Suppl 5:S50–6.
13. Oswald, I. In: Sleep. London: Pelican (ed). (1966).
14. Maquet P, Peters J, Aerts J, et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature. 1996;383:163–6.
15. Nofzinger EA, Mintun MA, Wiseman M, Kupfer DJ, Moore RY. Forebrain activation in REM sleep: an FDG PET study. Brain Res. 1997;770(1–2):192–201.
16. Siegel JM. REM sleep: a biological and psychological paradox. Sleep Med Rev. 2011;15(3):139–42.
17. Ho AP, Gillin JC, Buchsbaum MS, et al. Brain glucose metabolism during non-rapid eye movement sleep in major depression: a positron emission tomography study. Arch Gen Psychiatry. 1996;53:645–52.
18. Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, et al. Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F] FDG PET studies. Psychiatry Res. 1999;91(2):59–78.
19. Nofzinger EA, Berman S, Fasiczka A, et al. Effects of bupropion SR on anterior paralimbic function during waking and REM sleep in depression: preliminary findings using [18F]-FDG PET. Psychiatry Res. 2001;106:95–111.
20. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry. 2004;161(11):2126–8.
21. Nofzinger EA. What can neuroimaging findings tell us about sleep disorders? Sleep Med. 2004;5 Suppl 1:S16–22.
22. Li Y, Wang E, Zhang H, Dou S, Liu L, Tong L, et al. Functional connectivity changes between parietal and prefrontal cortices in primary insomnia patients: evidence from resting-state fMRI. Eur J Med Res. 2014;19(1):32.
23. Vitiello MV, Prinz PN, Williams DE, Frommlet MS, Ries RK. Sleep disturbances in patients with mild-stage Alzheimer’s disease. J Gerontol. 1990;45(4):M131–8.
24. McCurry SM, Logsdon RG, Teri L, Gibbons LE, Kukull WA, Bowen JD, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J Geriatr Psychiatry Neurol. 1999;12(2):53–9.
25. Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Med. 2005;6(4):347–52.
26. Song Y, Dowling GA, Wallhagen MI, Lee KA, Strawbridge WJ. Sleep in older adults with Alzheimer’s disease. J Neurosci Nurs. 2010;42(4):190–8.
27. Bonanni E, Maestri M, Tognoni G, Fabbrini M, Nucciarone B, Manca ML, et al. Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment. J Sleep Res. 2005;14(3):311–7.
28. Gagnon JF, Petit D, Fantini ML, Rompré S, Gauthier S, Panisset M, et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep. 2006;29(10):1321–5.
29. Kundermann B, Thum A, Rocamora R, Haag A, Krieg JC, Hemmeter U. Comparison of polysomnographic variables and their relationship to cognitive impairment in patients with Alzheimer’s disease and frontotemporal dementia. J Psychiatr Res. 2011;45(12):1585–92.
30. Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer’s disease: epidemiology, pathophysiology and treatment. CNS Drugs. 2001;15:777–96.
31. Okawa M, Mishima K, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep. 1991;14(6):478–85.
32. Yevchak AM, Steis MR, Evans LK. Sundown syndrome: a systematic review of the literature. Res Gerontol Nurs. 2012;5(4):294–303.
33. Ismail Z, Herrmann N, Francis PL, Rothenburg LS, Lobaugh NJ, Leibovitch FS, et al. A SPECT study of sleep disturbance and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2009;27(3):254–9.
34. Eggers C, Szelies B, Bauer B, Wienhard K, Schröder H, Herholz K, et al. Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness. Eur J Neurol. 2007;14(6):690–3.
35. Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bilgel M, et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013;70(12):1537–43. This is an interesting study as it suggests that sleep disturbance might cause or accelerate Alzheimer’s disease. The findings need to be confirmed in future studies.
36. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005–7.
37. Tractenberg RE, Singer CM, Kaye JA. Symptoms of sleep disturbance in persons with Alzheimer’s disease and normal elderly. J Sleep Res. 2005;14(2):177–85.
38. Cheng CY, Tsai CF, Wang SJ, Hsu CY, Fuh JL. Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia. J Geriatr Psychiatry Neurol. 2013;26(3):158–64.
39. Chaudhuri KR. Nocturnal symptom complex in PD and its management. Neurology. 2003;61 Suppl 3:S17–23.
40. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA. 2002;287(4):455–63.
41. Rye DB. Excessive daytime sleepiness and unintended sleep in Parkinson’s disease. Curr Neurol Neurosci Rep. 2006;6(2):169–76.
42. Comella CL. Sleep disorders in Parkinson’s disease. Curr Treat Options Neurol. 2008;10(3):215–21.
43. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology. 2002;58(3):341–6.
44. Happe S, Baier PC, Helmschmied K, Meller J, Tatsch K, Paulus W. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson’s disease. J Neurol. 2007;254(8):1037–43.
45. Happe S, Pirker W, Klösch G, Sauter C, Zeitlhofer J. Periodic leg movements in patients with Parkinson’s disease are associated with reduced striatal dopamine transporter binding. J Neurol. 2003;250(1):83–6.
46. Happe S, Anderer P, Pirker W, Klösch G, Gruber G, Saletu B, et al. Sleep microstructure and neurodegeneration as measured by [123I] beta-CIT SPECT in treated patients with Parkinson’s disease. J Neurol. 2004;251(12):1465–71.
47. Pavese N, Metta V, Simpson BS, Murphy TA, Ramlackhansingh A, Chaudhuri KR, et al. Sleep regulatory centres dysfunction in Parkinson’s disease patients with excessive daytime sleepiness. An in vivo PET study. Parkinsonism Relat Disord. 2012;18(Supplement 2):S24–5. In this paper, eleven Parkinson’s disease patients (PD) with Excessive daytime sleepiness (EDS) and ten without EDS were assessed with 18F-dopa and 11C-DASB. For each tracer, PET findings in PD patients were compared with those of ten healthy volunteers. PET images were analyzed with region of interest approach and whole brain voxel-by-voxel analysis. Both methods provide evidence that monoaminergic dysfunction in the neuronal networks responsible for the establishment and maintenance of wakefulness contributes to EDS in PD.
48. Gama RL, Távora DG, Bomfim RC, Silva CE, de Bruin VM, de Bruin PF. Sleep disturbances and brain MRI morphometry in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy—a comparative study. Parkinsonism Relat Disord. 2010;16(4):275–9.
49. Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, et al. Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepiness. Parkinsonism Relat Disord. 2006;12(5):319–22.
50. Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, et al. Excessive daytime sleepiness in Parkinson disease: a SPECT study. Sleep. 2006;29(7):917–20.
51. Hilker R, Razai N, Ghaemi M, Weisenbach S, Rudolf J, Szelies B, et al. [18F] fluorodopa uptake in the upper brainstem measured with positron emission tomography correlates with decreased REM sleep duration in early Parkinson’s disease. Clin Neurol Neurosurg. 2003;105(4):262–9.
52. Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, et al. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C] DASB PET imaging study. PLoS One. 2012;7(7):e40166.
53. Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry. 1997;58:369–76.
54. Chiu HF, Wing YK, Lam LC, Li SW, Lum CM, Leung T, et al. Sleep-related injury in the elderly—an epidemiological study in Hong Kong. Sleep. 2000;23(4):513–7.
55. Comella CL, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology. 1998;51(2):526–9.
56. Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. J Neurol Neurosurg Psychiatry. 2008;79(4):387–91.
57. Nomura T, Inoue Y, Högl B, Uemura Y, Kitayama M, Abe T, et al. Relationship between (123) I-MIBG scintigrams and REM sleep behavior disorder in Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(10):683–5.
58. Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, et al. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol. 2012;71(4):560–8. Findings from this study provide evidence that cholinergic dysfunction rather than degeneration of monoaminergic pathways are involved in the occurrence of RBD in Parkinson’s disease
59. Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006;5(7):572–7.
60. Postuma RB, Gagnon JF, Rompré S, Montplaisir JY. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. 2010;74(3):239–44.
61. Iranzo A, Valldeoriola F, Lomeña F, Molinuevo JL, Serradell M, Salamero M, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011;10(9):797–805.
62. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep. 2003;26(5):507–12.
63. Kim YK, Yoon IY, Kim JM, Jeong SH, Kim KW, Shin YK, et al. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol. 2010;17(3):487–92.
64. Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82(7):620–7. Findings from this study are very interesting as they indicate that patients with REM sleep behavior disorder have latent network abnormalities that could be predictive of subsequent phenoconversion to Parkinson’s disease or other synucleinopathies.